Shuttle Pharmaceuticals Holdings announced the appointment of Timothy Lorber, CPA, as the company Chief Financial Officer. The company’s current Chief Financial Officer, Michael Vander Hoek, who also serves as our Vice President, Regulatory, will be transitioning out of his role as Chief Financial Officer and will assume the Vice President, Regulatory position on a full-time basis.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SHPH:
- Shuttle Pharma Appoints Timothy Lorber as Chief Financial Officer
- Shuttle Pharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
- Shuttle Pharmaceuticals provides Q1 update
- Shuttle Pharma Provides First Quarter 2024 Corporate Update
- Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1×1 Meetings on Thursday, May 2, 2024